Cited by 937COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchMalaria Research and Control

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Open access

Colson, Philippe, Rolain, Jean-Marc, Lagier, Jean-Christophe, Brouqui, Philippe, Raoult, Didier·2020·International Journal of Antimicrobial Agents

DOI 10.1016/j.ijantimicag.2020.105932PMC PMC7135139

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ijantimicag.2020.105932

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731
Whipple's Disease
Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651
Self-citation
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644
New insights into the antiviral effects of chloroquine
Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471
Self-citation
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Rolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408
Self-citation

Show all 26 references

Sorted by citations

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Self-citation
Retracted
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,392
Coronavirus Disease 2019–COVID-19
Dhama, K., Sharun, K., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,993
COVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., BUONO, R. D., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,435
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz‐Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,333
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J. M., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,174
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A. K., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,167
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Devaux, C. A., Rolain, J., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,122
Self-citation
The epidemiology, diagnosis and treatment of COVID-19
Zhai, P., Ding, Y., Wu, X., Long, J., Zhong, Y., & Li, Y. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105955 · Cited by 1,040
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trialPreprint
Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 861
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Sevestre, J., Mailhe, M., Doudier, B., Aubry, C., Amrane, S., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101663 · Cited by 775
Self-citation
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies
Sharma, A., Tiwari, S., Deb, M. K., & Marty, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106054 · Cited by 734
An Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H. D., Shannar, A., Peter, R. M., Chou, P. J., Li, S. N., Hudlikar, R. R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 600
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Fantini, J., Scala, C. D., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105960 · Cited by 566
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Τσούπρας, Α. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 553
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
Boopathi, S., Poma, A. B., & Kolandaivel, P. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758788 · Cited by 549
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Lai, C.-C., Wang, C., & Hsueh, P. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.05.013 · Cited by 491
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.011 · Cited by 493
Drug repositioning: a brief overview
Jourdan, J.-P., Bureau, R., Rochais, C., & Dallemagne, P. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13273 · Cited by 470
Clinical management of COVID-19
Varghese, G. M., John, R., Abi Manesh, S., Rajiv Karthik, K., & Abraham, O. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_957_20 · Cited by 500
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A., & Ackerman, M. J. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.024 · Cited by 394
The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper
Stawicki, S. P., Jeanmonod, R., Miller, A., Paladino, L., Gaieski, D. F., Yaffee, A. Q., Wulf, A. D., Grover, J., Papadimos, T. J., Bloem, C. M., et al. (2020) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_86_20 · Cited by 388
A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M., & Halim, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761883 · Cited by 339
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
McCreary, E. K., & Pogue, J. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa105 · Cited by 334
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Andréani, J., Bideau, M. L., Duflot, I., Jardot, P., Rolland, C., Boxberger, M., Wurtz, N., Rolain, J., Colson, P., Scola, B. L., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104228 · Cited by 324
Self-citation
The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
Alanagreh, L., Alzoughool, F., & Atoum, M. F. M. (2020) · Pathogens · doi:10.3390/pathogens9050331 · Cited by 315
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
Mirza, M. U., & Froeyen, M. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.04.008 · Cited by 293
Current pharmacological treatments for COVID‐19: What's next?
Scavone, C., Brusco, S., Bertini, M., Sportiello, L., Rafaniello, C., Zoccoli, A., Berrino, L., Racagni, G., Rossi, F., & Capuano, A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15072 · Cited by 289
Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
Paital, B., Das, K., & Parida, S. K. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138914 · Cited by 287
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Misra, D. P., Agarwal, V., Gasparyan, A. Y., & Zimba, O. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05073-9 · Cited by 275
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30276-9 · Cited by 258
Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?
Gurunathan, S., Qasim, M., Choi, Y., Tae, J., Park, C., Hong, K., Kim, J., & Song, H. (2020) · Nanomaterials · doi:10.3390/nano10091645 · Cited by 259
Therapeutic management of patients with COVID-19: a systematic review
Tobaiqy, M. A., Qashqary, M. E., Aldahery, S. T., Mujallad, A., Hershan, A. A., Kamal, M. A., & Helmi, N. M. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100061 · Cited by 243
Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
Sportelli, M. C., Izzi, M., Kukushkina, E. A., Hossain, S. I., Picca, R. A., Ditaranto, N., & Cioffi, N. (2020) · Nanomaterials · doi:10.3390/nano10040802 · Cited by 244
When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19
Erku, D., Belachew, S. A., Abrha, S., Sinnollareddy, M., Thomas, J., Steadman, K. J., & Tesfaye, W. H. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.032 · Cited by 242
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
Alijotas‐Reig, J., Esteve‐Valverde, E., Belizna, C. C., Selva-O’Callaghan, A., Pardos‐Gea, J., Quintana, Á., MEKINIAN, A., Anunciación-Llunell, A., & Miró‐Mur, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102569 · Cited by 239
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
Hernández, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2496 · Cited by 226
Coronavirus lockdown helped the environment to bounce back
Arora, S., Bhaukhandi, K. D., & Mishra, P. K. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140573 · Cited by 220
A new threat from an old enemy: Re‑emergence of coronavirus (Review)
Docea, A. O., Tsatsakis, A. M., Albulescu, D. M., Cristea, O. M., Zlatian, O. M., Vinceti, M., Moschos, S. A., Tsoukalas, D., Γούμενου, Μ., Drakoulis, N., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4555 · Cited by 221
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
Maurya, V. K., Kumar, S., Prasad, A. K., Bhatt, M. L. B., & Saxena, S. K. (2020) · VirusDisease · doi:10.1007/s13337-020-00598-8 · Cited by 221
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013587.pub2 · Cited by 225
Hydroxychloroquine and COVID-19
Sinha, N., & Balayla, G. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137785 · Cited by 205
Biological and social aspects of Coronavirus Disease 2019 (COVID-19) related to oral health
Pereira, L. J., Pereira, C. V., Murata, R. M., Pardi, V., & Pereira, S. M. (2020) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2020.vol34.0041 · Cited by 205
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Derwand, R., & Scholz, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109815 · Cited by 192
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
Cicco, S., Cicco, G., Racanelli, V., & Vacca, A. (2020) · Mediators of Inflammation · doi:10.1155/2020/7527953 · Cited by 195
Can melatonin reduce the severity of COVID-19 pandemic?
Shneider, A., Kudriavtsev, A. V., & Vakhrusheva, A. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1756284 · Cited by 185
COVID-19 and Older Adult
Morley, J. E., & Vellas, B. (2020) · The Journal of nutrition, health and aging · doi:10.1007/s12603-020-1349-9 · Cited by 173
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents
Kanjanasirirat, P., Suksatu, A., Manopwisedjaroen, S., Munyoo, B., Tuchinda, P., Jearawuttanakul, K., Seemakhan, S., Charoensutthivarakul, S., Wongtrakoongate, P., Rangkasenee, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77003-3 · Cited by 174
O Coração e a COVID-19: O que o Cardiologista Precisa Saber
Costa, I. B. S. D. S., Bittar, C. S., Rizk, S. I., de Araújo, A. E., dos Santos, K. K. M., Machado, T. I. V., Andrade, F. T. D. A., González, T. B., Arévalo, A. N. G., de Almeida, J. P., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200279 · Cited by 194
Psychosocial Effects of the COVID-19 Pandemic: Large-scale Quasi-Experimental Study on Social Media
Saha, K., Torous, J., Caine, E. D., & De Choudhury, M. (2020) · Journal of Medical Internet Research · doi:10.2196/22600 · Cited by 166
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Ita, K. B. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.010 · Cited by 164
Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait
Almazeedi, S. M., Al‐Youha, S., Jamal, M. H., Al‐Haddad, M., Al‐Muhaini, A., Al-Ghimlas, F., & Al-Sabah, S. K. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100448 · Cited by 165
COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches
Moccia, F. D., Gerbino, A., Lionetti, V., Miragoli, M., Munaron, L., Pagliaro, P., Pasqua, T., Penna, C. R. R., Rocca, C., Samaja, M., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00198-w · Cited by 165
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
Perricone, C., Triggianese, P., Bartoloni, E., Cafaro, G., Bonifacio, A. F., Bursi, R., Perricone, R., & Gerli, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102468 · Cited by 158
Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
Huang, J., Song, W., Huang, H., & Sun, Q. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041131 · Cited by 165
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine
Alexander, P. E., Debono, V. B., Mammen, M. J., Iorio, A., Aryal, K., Deng, D., Brocard, E., & Alhazzani, W. A. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.04.016 · Cited by 157
Topological indices and QSPR / QSAR analysis of some antiviral drugs being investigated for the treatment of COVID ‐19 patients
Kirmani, S. A. K., Ali, P., & Azam, F. (2020) · International Journal of Quantum Chemistry · doi:10.1002/qua.26594 · Cited by 157
Cardiac Arrhythmias in COVID-19 Infection
Kochav, S. M., Coromilas, E. J., Nalbandian, A., Ranard, L. S., Gupta, A., Chung, M. K., Gopinathannair, R., BIVIANO, A. B., Garan, H., & Wan, E. Y. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008719 · Cited by 153
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation
Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74468-0 · Cited by 149
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens
Momekov, G., & Momekova, D. B. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1775118 · Cited by 145
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)
Huang, F., Li, Y., Leung, E. L., Liu, X., Liu, K., Qu, W., Lan, Y., Li, X., Yu, H., Cui, L., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104929 · Cited by 140
COVID-19 research: pandemic versus “paperdemic”, integrity, values and risks of the “speed science”
Dinis‐Oliveira, R. J. (2020) · Forensic Sciences Research · doi:10.1080/20961790.2020.1767754 · Cited by 137
A Comprehensive Review About SARS-CoV-2
Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K. (2020) · Future Virology · doi:10.2217/fvl-2020-0124 · Cited by 121
A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease
Ferrey, A., Choi, G., Hanna, R. M., Chang, Y., Tantisattamo, E., Ivaturi, K., Park, E., Nguyen, L., Wang, B., Tonthat, S., et al. (2020) · American Journal of Nephrology · doi:10.1159/000507417 · Cited by 127
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
Hashem, A. M., Alghamdi, B. S. A., Algaissi, A. A., Alshehri, F. S., Bukhari, A. I., Alfaleh, M. A., & Memish, Z. A. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101735 · Cited by 131
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Khadke, S., Ahmed, N., Ahmed, N., Ratts, R., Raju, S., Gallogly, M. M., Lima, M. J. G. D., & Sohail, M. R. (2020) · Virology Journal · doi:10.1186/s12985-020-01415-w · Cited by 127
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
Mercurio, I., Tragni, V., Busto, F., Grassi, A., & Pierri, C. L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03580-1 · Cited by 129
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
Khorramdelazad, H., Kazemi, M. H., Najafi, A., Keykhaee, M., Emameh, R. Z., & Falak, R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104554 · Cited by 127
Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic
Clemente‐Suárez, V. J., Hormeño-Holgado, A. J., Jiménez, M., Benítez-Agudelo, J. C., Navarro-Jiménez, E., Perez-Palencia, N., Serrano, R. Y. M., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2020) · Vaccines · doi:10.3390/vaccines8020236 · Cited by 126
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
Rauf, A., Abu‐Izneid, T., Olatunde, A., Khalil, A. A., Alhumaydhi, F. A., Tufail, T., Shariati, M. A., Ребезов, М. Б., Almarhoon, Z. M., Mabkhot, Y. N., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218155 · Cited by 134
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Palacios-Rápalo, S. N., Jesús‐González, L. A. D., Cordero‐Rivera, C. D., Farfán-Morales, C. N., Osuna‐Ramos, J. F., Martínez-Mier, G., Quistián-Galván, J., Muñoz-Pérez, A., Bernal-Dolores, V., del Ángel, R. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796855 · Cited by 125
YouTube as a source of information on COVID-19 and rheumatic disease link
Koçyiğit, B. F., Akaltun, M. S., & Şahin, A. R. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05176-3 · Cited by 120
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
White, N. J., Watson, J. A., Hoglund, R. M., Chan, X. H. S., Cheah, P. Y., & Tärning, J. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003252 · Cited by 119
DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19
Noureddine, O., Issaoui, N., & Al-Dossary, O. M. (2020) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2020.101248 · Cited by 119
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
Li, H., Liu, Z., & Ge, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15364 · Cited by 127
Incidence of COVID‐19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?
Favalli, E. G., Monti, S. M., Ingegnoli, F., Balduzzi, S., Caporali, R. F., & Montecucco, C. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41388 · Cited by 118
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
Fantini, J., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106020 · Cited by 119
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
Tripathy, S., Dassarma, B., Roy, S., Chabalala, H. P., & Matsabisa, M. G. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106028 · Cited by 116
Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles
Basheti, I. A., Nassar, R. I., Barakat, M. M., Alqudah, R., Farha, R. K. A., Mukattash, T. L., & Saini, B. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.020 · Cited by 121
Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19
Talluri, S. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323666200814132149 · Cited by 119
Antimicrobial Photodynamic Therapy in the Control of COVID-19
Almeida, A., Faustino, M. A. F., & Neves, M. G. P. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9060320 · Cited by 112
COVID-19 challenges and its therapeutics
Rehman, S. U., Rehman, S. U., & Yoo, H. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112015 · Cited by 113
SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
Fiscon, G., Conte, F., Farina, L., & Paci, P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008686 · Cited by 108
Review article: prevention, diagnosis and management of COVID‐19 in the IBD patient
Al‐Ani, A., Prentice, R., Rentsch, C. A., Johnson, D., Ardalan, Z. S., Heerasing, N. M., Garg, M., Campbell, S., Sasadeusz, J. J., Macrae, F., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15779 · Cited by 103
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
Satarker, S., Ahuja, T. N., Banerjee, M., Vignesh Balaji, E., Dogra, S. S., Agarwal, T., & Nampoothiri, M. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00231-8 · Cited by 106
Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain
Escalera-Antezana, J. P., Lizon-Ferrufino, N. F., Maldonado-Alanoca, A., Alarcón-De-la-Vega, G., Alvarado-Arnez, L. E., Balderrama-Saavedra, M. A., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101653 · Cited by 102
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Gasmi, A., Peana, M., Noor, S., Lysiuk, R., Menzel, A., Benahmed, A. G., & Bjørklund, G. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11094-4 · Cited by 103
ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication
Qu, Y., Wang, X., Zhu, Y., Wang, W., Wang, Y., Hu, G., Liu, C., Li, J., Ren, S., Xiao, M. Z. X., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716208 · Cited by 116
The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics
Abbasifard, M., & Khorramdelazad, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118097 · Cited by 101
FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Lobo-Galo, N., Terrazas-López, M., Martı́nez-Martı́nez, A., & Díaz‐Sánchez, Á. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764393 · Cited by 98
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
Fathi, M., Vakili, K. G., Sayehmiri, F., Mohamadkhani, A., Hajiesmaeili, M., Rezaei–Tavirani, M., & Eilami, O. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246190 · Cited by 103
Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19
Rakib, A., Paul, A., Chy, M. N. U., Sami, S. A., Baral, S. K., Majumder, M., Tareq, A. M., Amin, M. N., Shahriar, A., Uddin, M. Z., et al. (2020) · Molecules · doi:10.3390/molecules25173936 · Cited by 96
Treatment Considerations for COVID-19
Vijayvargiya, P., Garrigos, Z. E., Almeida, N. E. C., Gurram, P. R., Stevens, R. W., & Razonable, R. R. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.027 · Cited by 94
Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies
Romano, S., Galante, H., Figueira, D., Mendes, Z., & Rodrigues, A. T. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.05.024 · Cited by 84
Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
Nadeem, M. S., Zamzami, M. A., Choudhry, H., Murtaza, B. N., Kazmi, I. A., Ahmad, H., & Shakoori, A. R. (2020) · Pathogens · doi:10.3390/pathogens9040307 · Cited by 95
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
Mitra, R. L., Greenstein, S. A., & Epstein, L. M. (2020) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2020.03.016 · Cited by 92
Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society
Kapoor, A., Pandurangi, U. M., Arora, V., Gupta, A. K., Jaswal, A., Nabar, A., Naik, A. M., Naik, N., Namboodiri, N., Vora, A. M., et al. (2020) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2020.04.003 · Cited by 92
A Bibliometric Network Analysis of Coronavirus during the First Eight Months of COVID-19 in 2020
Furstenau, L. B., Rabaioli, B., Sott, M. K., Cossul, D., Bender, M. S., Farina, E. M. J. D. M., Filho, F. N. B., Severo, P. P., Dohan, M. S., & Bragazzi, N. L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030952 · Cited by 96
Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies
Baildya, N., Ghosh, N. N., & Chattopadhyay, A. P. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128595 · Cited by 80
Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
Soto, M. E., Guarner‐Lans, V., Soria‐Castro, E., Pech, L. M., & Pérez-Torres, I. (2020) · Medicina · doi:10.3390/medicina56080386 · Cited by 84

Authors: Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D.
Affiliations: Aix-Marseille Université (FR)
Corresponding author: Raoult, Didier
ORCID: Colson, Philippe
Rolain, Jean-Marc
Lagier, Jean-Christophe
Brouqui, Philippe
Raoult, Didier
Venue: International Journal of Antimicrobial Agents
Publisher: Elsevier BV
Published: 2020-04
Volume: 55
Issue: 4
Pages: 105932
ISSN: 0924-8579 (ISSN-L)
DOI: 10.1016/j.ijantimicag.2020.105932
PMC: PMC7135139
OpenAlex: W3010277308
Cited by: 937
References: 26
Citations by year: 2026: 7 · 2025: 12 · 2024: 21 · 2023: 45 · 2022: 71 · 2021: 215 · 2020: 564
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (am, 386 d)
Locations: International Journal of Antimicrobial Agents (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Funders: Agence Nationale de la Recherche (ANR-10-IAHU-0003)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
Keywords: chloroquine, hydroxychloroquine, COVID-19 pandemic, SARS-CoV-2, antimalarial drugs, antiviral therapy
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Adenosine Monophosphate, Alanine, Chloroquine, Hydroxychloroquine, Pneumonia, Viral, Coronavirus, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks